RICHMOND, Va., May 28, 2011 /PRNewswire/ -- Health Diagnostic Laboratory, Inc. (HDL, Inc.), www.myhdl.com, a CAP accreditedleader in health management, has received the Virginia Bioscience Company of the Year Award by the Virginia Biotechnology Association (VABIO). The award was designed to recognize the biotech or device company that best exemplifies the spirit of the
"Health Diagnostic Laboratory Inc. is honored to be a part of Virginia's vibrant life sciences community," said Tonya Mallory, CEO and Co-founder of HDL, Inc. "It's a true privilege to have the opportunity to work alongside so many impressive leaders in the biotech sector throughout the Commonwealth."
Finalists for the award included Adial Pharmaceuticals, Intelliject, and Tau Therapeutics, with Health Diagnostic Laboratory receiving the top honor. Criteria for the Virginia Bioscience Company of the Year Award included the achievement of significant, measurable success; contribution to the advancement of biosciences through cutting-edge research and development; a successfully executed growth strategy; and efforts to help foster a vibrant bioscience community within Virginia.
Mark A. Herzog, Executive Director of the Virginia Biotechnology Association, presented The Virginia Bioscience Company of the Year Award to HDL, Inc. on Thursday, May 26, 2011 at a special reception, titled Jobs and Innovation in the Pharmaceutical and Biotech Sector of Virginia, at the Pfizer research facility in Richmond. The 2011 Virginia Bioscience Company of the Year Award, presented by the Virginia Biotechnology Association, was sponsored by the law firm Cooley LLP and Pharmaceutical Researchers and Manufacturers of America.
The Virginia Biotechnology Association (VABIO) is the statewide trade group that promotes the considerable scientific and economic impact of the life sciences industry in the Commonwealth of Virginia. VABIO is the official state affiliate of the Biotechnology Industry Organization (BIO). For more information, visit www.vabio.org.
About HDL, Inc.:
Health Diagnostic Laboratory Inc. (HDL, Inc.), a CAP accredited leader in health management, offers a comprehensive test menu of risk factors and biomarkers for cardiovascular and related diseases. Our systematic approach identifies factors contributing to disease and provides a basis for effective personalized treatment, allowing physicians to more effectively manage patients. As an added value, patients receive a personalized overview of their risk factors along with intensive counseling from expert Health Coaches at no additional cost, improving compliance and enhancing potential outcomes. For more information, www.myhdl.com.
SOURCE HDL, Inc.
Subscribe to our Free Newsletters!
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...
Exotropia or outward eye deviation is a form of squint. Proper evaluation and timely intervention ...
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in ...View All